Investor relations pageIR page | no data available |
Founding year | no data available |
Headquarter | , , no data available |
Employees | 79 (as per Q2 2017)no data available |
Sector | Biotechnology, HealthcareBiotechnology, Healthcareno data available |
Ticker | CSBRno data available |
Financial year endsFY ends | End of Aprilno data available |
Last Closing Price as per Oct 13, 2017, in USD |
3.41n/a |
Market Capitalisation in million USD |
37n/a |
Enterprise Value in million USD |
33n/a |
Common Shares Outstanding as per Oct 31, 2016 |
10,967,491n/a |
Preferred Shares Outstanding as per Oct 31, 2016 |
n/a |
Average Basic Shares Outstanding TTM |
8,695,199n/a |
Average Diluted Shares Outstanding TTM |
9,124,125n/a |
Index Membership |
n/a
|
Revenues | 12n/a |
Gross Profit | 3n/a |
Operating Income | -10n/a |
EBITDA | 0n/a |
Net Profit | -10n/a |
Cash and Cash Equivalents | 5n/a |
Receivables | 2n/a |
Total Current Assets | 6n/a |
PP&E | 1n/a |
Total Assets | 8n/a |
Accounts Payable | 2n/a |
Current Debt | 0n/a |
Total Current Liabilities | 4n/a |
Long-Term Debt | 0n/a |
Total Liabilities | 5n/a |
Total Equity | 3n/a |
Depreciation & Amortisation | 0n/a |
Change in Working Capital | 0n/a |
Operating Cash Flow | 0n/a |
Net Change in PP&E and Intangibles | 0n/a |
Investing Cash Flow | 0n/a |
Dividends Paid | 0n/a |
Financing Cash Flow | 0n/a |
Total Change in Cash | 0n/a |
Free Cash Flow | 0n/a |
Gross Margin | 25.3%n/a |
Operating Margin | -82.6%n/a |
Net Profit Margin | -83.8%n/a |
Return on Equity | -317.4%n/a |
Return on Assets | -127.8%n/a |
Basic EPS | n/a |
Diluted EPS | n/a |
Sales per Share | n/a |
Book Value per Share | n/a |
FCF per Share | n/a |
Dividends per Share | n/a |
Price to Earnings Ratio | n/a |
Price to Sales Ratio | n/a |
Price to Book Value | n/a |
Price to Free Cash Flow | n/a |
EV/EBITDA | n/a |
EV/Sales | 2.73n/a |
Book to Market Value | 0.08n/a |
Current Ratio | 146.3%n/a |
Liabilities to Equity Ratio | 147.1%n/a |
Debt to Assets Ratio | 0.0%n/a |
in million USD | FY '11 | FY '12 | FY '13 | FY '14 | FY '15 | FY '16 |
---|---|---|---|---|---|---|
|
7
|
7
|
8
|
12
|
9
|
11
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
-4
|
-5
|
-5
|
-6
|
-8
|
-9
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
3
|
2
|
3
|
5
|
1
|
2
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
-9
|
-11
|
-9
|
-12
|
-14
|
-13
|
|
-6
|
-8
|
-7
|
-9
|
-10
|
-9
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
-3
|
-3
|
-2
|
-2
|
-5
|
-4
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
-5
|
-9
|
-6
|
-6
|
-13
|
-10
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
-5
|
-9
|
-6
|
-6
|
-13
|
-10
|
|
-1
|
0
|
0
|
1
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
-7
|
-9
|
-6
|
-5
|
-14
|
-10
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
-7
|
-9
|
-6
|
-5
|
-14
|
-10
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
-7
|
-9
|
-6
|
-5
|
-14
|
-10
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
-7
|
-9
|
-6
|
-5
|
-14
|
-10
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
-7
|
-9
|
-6
|
-5
|
-14
|
-10
|
Remarks |
restated on Jul 18, 2012
n/a
calculated values,
|
restated on Jul 26, 2013
n/a
calculated values,
|
restated on Jul 28, 2014
n/a
calculated values,
|
restated on Jul 29, 2015
n/a
calculated values,
|
restated on Jul 29, 2016
n/a
calculated values,
|
restated on Jul 29, 2016
n/a
calculated values,
|
in million USD | FY '11 | FY '12 | FY '13 | FY '14 | FY '15 | FY '16 |
---|---|---|---|---|---|---|
Assets | ||||||
|
10
|
5
|
10
|
6
|
9
|
3
|
|
10
|
5
|
10
|
6
|
9
|
3
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
1
|
1
|
1
|
1
|
1
|
1
|
|
1
|
1
|
1
|
1
|
1
|
1
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
1
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
1
|
0
|
0
|
0
|
0
|
0
|
|
12
|
6
|
10
|
8
|
11
|
4
|
|
0
|
1
|
0
|
0
|
0
|
1
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
1
|
1
|
1
|
1
|
1
|
1
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
1
|
1
|
1
|
1
|
1
|
1
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
1
|
1
|
1
|
1
|
1
|
1
|
|
13
|
7
|
12
|
9
|
12
|
6
|
Liabilities and owners' equity | ||||||
|
2
1882000
|
2
2301000
|
2
1815000
|
2
1568000
|
2
1787000
|
2
2167000
|
|
2
1580000
|
2
1676000
|
1
1204000
|
1
981000
|
1
1414000
|
2
1896000
|
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
|
0
302000
|
1
625000
|
1
611000
|
1
587000
|
0
373000
|
0
271000
|
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
|
2
1618000
|
1
1185000
|
1
1114000
|
2
2091000
|
2
2009000
|
3
3139000
|
|
2
1618000
|
1
1185000
|
1
1114000
|
2
2091000
|
2
2009000
|
3
3139000
|
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
|
4
3500000
|
3
3486000
|
3
2929000
|
4
3659000
|
4
3796000
|
5
5306000
|
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
|
1
972000
|
1
555000
|
1
1046000
|
2
2011000
|
0
192000
|
0
233000
|
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
|
1
972000
|
1
555000
|
1
1046000
|
2
2011000
|
0
0
|
0
0
|
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
|
0
0
|
0
0
|
0
0
|
0
0
|
0
192000
|
0
233000
|
|
1
972000
|
1
555000
|
1
1046000
|
2
2011000
|
0
192000
|
0
233000
|
|
4
4472000
|
4
4041000
|
4
3975000
|
6
5670000
|
4
3988000
|
6
5539000
|
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
|
18
17821000
|
21
21242000
|
24
23619000
|
43
43329000
|
61
61331000
|
64
63956000
|
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
|
-1
-1252000
|
-1
-1252000
|
-1
-1252000
|
-1
-1252000
|
-1
-1252000
|
-1
-1252000
|
|
-16
-16482000
|
-25
-25143000
|
-31
-31473000
|
-39
-38880000
|
-52
-52020000
|
-62
-62466000
|
|
0
-68000
|
0
-125000
|
0
-100000
|
0
0
|
0
0
|
0
0
|
|
0
19000
|
-5
-5278000
|
-9
-9206000
|
3
3197000
|
8
8059000
|
0
238000
|
|
8
8159000
|
8
8159000
|
17
16882000
|
0
0
|
0
0
|
0
0
|
|
8
8178000
|
3
2881000
|
8
7676000
|
3
3197000
|
8
8059000
|
0
238000
|
|
13
12650000
|
7
6922000
|
12
11651000
|
9
8867000
|
12
12047000
|
6
5777000
|
Remarks | restated on Jul 18, 2012 n/a | restated on Jul 26, 2013 n/a | restated on Jul 28, 2014 n/a | restated on Jul 29, 2015 n/a | restated on Jul 29, 2016 n/a | restated on Dec 14, 2016 n/a |
in million USD | FY '11 | FY '12 | FY '13 | FY '14 | FY '15 | FY '16 |
---|---|---|---|---|---|---|
|
-4
|
-9
|
-6
|
-7
|
-13
|
-10
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
3
|
3
|
2
|
4
|
3
|
3
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
1
|
1
|
-1
|
0
|
1
|
1
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
-5
|
-4
|
-3
|
-10
|
-6
|
|
0
|
-1
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
-1
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
9
|
0
|
9
|
0
|
13
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
-1
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
-1
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
8
|
0
|
9
|
0
|
13
|
0
|
|
8
|
-6
|
5
|
-4
|
3
|
-7
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
8
|
-6
|
5
|
-4
|
3
|
-7
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
8
|
-6
|
5
|
-4
|
3
|
-7
|
Remarks |
restated on Jul 18, 2012
n/a
calculated values,
|
restated on Jul 26, 2013
n/a
calculated values,
|
restated on Jul 28, 2014
n/a
calculated values,
|
restated on Jul 29, 2015
n/a
calculated values,
|
restated on Jul 29, 2016
n/a
calculated values,
|
restated on Jul 29, 2016
n/a
calculated values,
|